Abstract: . . .  351(9118): 1755-62. 14) Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin- converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342 (3): 45-53. 15) Vasan RS, Beiser A, Seshadri S, Larson M, Kannel WB, D'Agostino RB, Levy, D. Residual Lifetime . . .
. . .  A, Chockalingam A, Hamet P. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997; 10(10 Pt 1): 1097-102. 4) Zarnke KB, Campbell NRC, McAlister F, Levine M for the Canadian Hypertension Recommendations Working Group. A novel process for updating recommendations for managing hypertension : rationale and methods. Can J Cardiol 2000:16:1094-102. 5) The ALLHAT . . .
. . .  Prevention Evaluation Study Investigators. N Engl J Med 2000; 342 (3): 45-53. 15) Vasan RS, Beiser A, Seshadri S, Larson M, Kannel WB, D'Agostino RB, Levy, D. Residual Lifetime Risk for Developing Hypertension in Middle-aged Women and Men. JAMA. 2002; 287:1003-1010.  . . .
. . .  many of the issues in the management of hypertension in 2002 remain in 2003. The tools to control hypertension and to reduce cardiovascular disease are in our hands. The Canadian Hypertension Education Program will continue to advocate for hypertension treatment and control, increase awareness of the importance of optimum hypertension management, develop tools to aid health care professions . . .
. . .  Med 2003; 348:583-92. 7) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension . Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265 (24): 3255-64. 8) Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, et al. The Life Study Group. Cardiovascular morbidity . . .
. . .  1 May 2003 The Canadian Hypertension Education Program Recommendations: whats new, whats old but still important in 2003. The Bottom Line Version On behalf of the Evidence Based Recommendations Task Force of the Canadian Hypertension Education . . .
. . .  Page 10 10 References 1) The Canadian Hypertension Recommendations Working Group. The 2001 Canadian hypertension recommendations. What is new and what is old but still important. Can J Cardio l 2002; 18(6): 591-603. 2) World Health Organization. The World Health Report 2002. http://www.who.int/whr/2002 3) Joffres MR, Ghadirian . . .
--3000,7,214,3245,29034